Arterial therapies of non-colorectal cancer metastases to the liver (from chemoembolization to radioembolization)

Abdominal Imaging

Volumn 36, Issue 6, 2011, Pages 671-676

  Hoffmann, Ralf Thorsten ^a   Paprottka, P ^b   Jakobs, T F ^b   Trumm, C G ^b   Reiser, M F ^b  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Breast cancer; Malignant melanoma; Neuroendocrine tumors; Pancreatic cancer; Radioembolization; Selective internal radiotherapy; Transarterial chemoembolization

Indexed keywords

CISPLATIN; YTTRIUM 90;

ARTICLE; ARTIFICIAL EMBOLISM; BREAST CANCER; CANCER RADIOTHERAPY; CHEMOEMBOLIZATION; HUMAN; LIVER METASTASIS; MELANOMA; METASTASIS; NEUROENDOCRINE TUMOR; PANCREAS CANCER; PRIORITY JOURNAL; RADIATION DOSE; RADIOEMBOLIZATION; TRANSARTERIAL CHEMOEMBOLIZATION; TREATMENT CONTRAINDICATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CHEMOEMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MELANOMA; MICROSPHERES; NEUROENDOCRINE TUMORS; PANCREATIC NEOPLASMS; YTTRIUM RADIOISOTOPES;

EID: 83055181564     PISSN: 09428925     EISSN: 14320509     Source Type: Journal    
DOI: 10.1007/s00261-011-9753-6     Document Type: Article

References (32)

1. R Salem KG Thurston 2006 Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: technical and methodologic considerations J Vasc Interv Radiol 17 8 1251 1278 16923973 10.1097/01.RVI.0000233785.75257.9A (Pubitemid 44259009)
2. EK Abdalla, et al. 2004 Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases Ann Surg 239 6 818 825 15166961 10.1097/01.sla. 0000128305.90650.71 discussion 825-827 (Pubitemid 38669432)
3. MF Mulcahy, et al. 2009 Radioembolization of colorectal hepatic metastases using yttrium-90 microspheres Cancer 115 9 1849 1858 19267416 10.1002/cncr.24224
4. C Breedis G Young 1954 The blood supply of neoplasms in the liver Am J Pathol 30 5 969 977 13197542 1:STN:280:DyaG2M%2FgvFWhtw%3D%3D
5. J Lammer, et al. 2010 Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study Cardiovasc Intervent Radiol 33 1 41 52 19908093 10.1007/s00270-009-9711-7
6. JL Raoul, et al. 1992 Chemoembolization of hepatocellular carcinomas. A study of the biodistribution and pharmacokinetics of doxorubicin Cancer 70 3 585 590 1320447 10.1002/1097-0142(19920801)70:3<585::AID-CNCR2820700308>3.0. CO;2-# 1:STN:280:DyaK38zitlCrsw%3D%3D
7. CF Gonsalves DB Brown 2009 Chemoembolization of hepatic malignancy Abdom Imaging 34 557 565 18668189 10.1007/s00261-008-9446-y
8. MS Chen, et al. 2002 High-dose iodized oil transcatheter arterial chemoembolization for patients with large hepatocellular carcinoma World J Gastroenterol 8 1 74 78 11833075
9. S Higashi, et al. 1999 Size of lipid microdroplets effects results of hepatic arterial chemotherapy with an anticancer agent in water-in-oil-in-water emulsion to hepatocellular carcinoma J Pharmacol Exp Ther 289 2 816 819 10215657 1:CAS:528:DyaK1MXislGju7k%3D (Pubitemid 29191236)
10. JG Touzios, et al. 2005 Neuroendocrine hepatic metastases: does aggressive management improve survival? Ann Surg 241 5 776 783 15849513 10.1097/01.sla.0000161981.58631.ab discussion 783-785 (Pubitemid 40604923)
11. D Yip, et al. 2004 Radiation-induced ulceration of the stomach secondary to hepatic embolization with radioactive yttrium microspheres in the treatment of metastatic colon cancer J Gastroenterol Hepatol 19 3 347 349 14748889 10.1111/j.1440-1746.2003.03322.x (Pubitemid 38338751)
12. WY Lau, et al. 1998 Selective internal radiation therapy for nonresectable hepatocellular carcinoma with intraarterial infusion of 90yttrium microspheres Int J Radiat Oncol Biol Phys 40 3 583 592 9486608 10.1016/S0360-3016(97)00818-3 1:STN:280:DyaK1c7ks1SisQ%3D%3D (Pubitemid 28104228)
13. SM Ibrahim P Nikolaidis FG Miller, et al. 2009 Radiologic findings following Y90 radioembolization for primary liver malignancies Abdom Imaging 34 566 581 18777189 10.1007/s00261-008-9454-y
14. A Riaz, et al. 2009 Complications following radioembolization with yttrium-90 microspheres: a comprehensive literature review J Vasc Interv Radiol 20 9 1121 1130 19640737 10.1016/j.jvir.2009.05.030 quiz 1131
15. E Viadana ID Bross JW Pickren 1973 An autopsy study of some routes of dissemination of cancer of the breast Br J Cancer 27 4 336 340 4701705 10.1038/bjc.1973.40 1:STN:280:DyaE3s7ntVahsA%3D%3D
16. MF Giroux RA Baum MC Soulen 2004 Chemoembolization of liver metastasis from breast carcinoma J Vasc Interv Radiol 15 3 289 291 15028815 (Pubitemid 38316452)
17. TF Jakobs, et al. 2008 Radioembolization in patients with hepatic metastases from breast cancer J Vasc Interv Radiol 19 5 683 690 18440456 10.1016/j.jvir.2008.01.009
18. AK Bangash, et al. 2007 90Y radioembolization of metastatic breast cancer to the liver: toxicity, imaging response, survival J Vasc Interv Radiol 18 5 621 628 17494843 10.1016/j.jvir.2007.02.019 (Pubitemid 46661173)
19. DM Coldwell AS Kennedy CW Nutting 2007 Use of yttrium-90 microspheres in the treatment of unresectable hepatic metastases from breast cancer Int J Radiat Oncol Biol Phys 69 3 800 804 17524567 10.1016/j.ijrobp.2007.03.056 1:CAS:528:DC%2BD2sXhtVOitrbK (Pubitemid 47418394)
20. R Murthy, et al. 2008 Yttrium-90 microsphere radioembolotherapy of hepatic metastatic neuroendocrine carcinomas after hepatic arterial embolization J Vasc Interv Radiol 19 1 145 151 18192482 10.1016/j.jvir.2007.09.006
21. DC Madoff, et al. 2006 Update on the management of neuroendocrine hepatic metastases J Vasc Interv Radiol 17 8 1235 1249 16923972 10.1097/01.RVI. 0000232177.57950.71 quiz 1250 (Pubitemid 44259008)
22. CF Gonsalves DB Brown 2009 Chemoembolization of hepatic malignancy Abdom Imaging 34 5 557 565 18668189 10.1007/s00261-008-9446-y
23. S Gupta, et al. 2005 Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival Cancer 104 8 1590 1602 16134179 10.1002/cncr.21389 (Pubitemid 41437421)
24. TK Rhee, et al. 2008 90Y Radioembolization for metastatic neuroendocrine liver tumors: preliminary results from a multi-institutional experience Ann Surg 247 6 1029 1035 18520231 10.1097/SLA.0b013e3181728a45 (Pubitemid 351770424)
25. AS Kennedy, et al. 2008 Radioembolization for unresectable neuroendocrine hepatic metastases using resin 90Y-microspheres: early results in 148 patients Am J Clin Oncol 31 3 271 279 18525307 10.1097/COC.0b013e31815e4557
26. H Ahmadzadehfar HJ Biersack S Ezziddin 2010 Radioembolization of liver tumors with yttrium-90 microspheres Semin Nucl Med 40 2 105 121 20113679 10.1053/j.semnuclmed.2009.11.001
27. M Kalinowski, et al. 2009 Selective internal radiotherapy with Yttrium-90 microspheres for hepatic metastatic neuroendocrine tumors: a prospective single center study Digestion 79 3 137 142 19307736 10.1159/000209849
28. GM Mavligit, et al. 1988 Regression of ocular melanoma metastatic to the liver after hepatic arterial chemoembolization with cisplatin and polyvinyl sponge JAMA 260 7 974 976 3398202 10.1001/jama.260.7.974 1:STN:280: DyaL1c3os12kug%3D%3D
29. AY Bedikian, et al. 1995 Treatment of uveal melanoma metastatic to the liver: a review of the M. D. Anderson Cancer Center experience and prognostic factors Cancer 76 9 1665 1670 8635073 10.1002/1097-0142(19951101)76:9<1665:: AID-CNCR2820760925>3.0.CO;2-J 1:CAS:528:DyaK28XjtFCi
30. KV Sharma, et al. 2008 Hepatic arterial chemoembolization for management of metastatic melanoma AJR Am J Roentgenol 190 1 99 104 18094299 10.2214/AJR.07.2675
31. R Schuster, et al. 2010 Transarterial chemoembolization of liver metastases from uveal melanoma after failure of systemic therapy: toxicity and outcome Melanoma Res 20 3 191 196 20335820 1:CAS:528:DC%2BC3cXls1Cmt7s%3D
32. AS Kennedy, et al. 2009 A first report of radioembolization for hepatic metastases from ocular melanoma Cancer Invest 27 6 682 690 19219675 10.1080/07357900802620893 1:CAS:528:DC%2BD1MXnvVOmtLs%3D